Static

Synchron Pauses Trials of Its Brain Implant Due to Performance Issues

First reported by Wired ·

The signal ●○○○ Compiled by AI from Wired, the single source so far
Why you might care

Brain implant trials face new hardware delays, pushing the commercial availability of thought-controlled devices further out.

What happened

Synchron, a brain-computer interface startup, has voluntarily paused enrollment in its trials for its second-generation Stentrode device due to a performance issue. The problem specifically affects the lead, a cable that transmits signals from the Stentrode to implanted electronics, and not the Stentrode itself. No safety concerns have been identified, and the pause is not FDA-directed. Synchron is undertaking a restructuring, including job cuts and relocating some operations to San Diego, to focus on designing and manufacturing an upgraded Stentrode system in-house. This upgrade aims to enhance overall system performance before resuming trial enrollment. The company has previously demonstrated its Stentrode's ability to enable users to control digital devices like computers and tablets using only their thoughts, with its first-generation device successfully implanted in ten volunteers.

What it means

The voluntary pause in Synchron's trials highlights the significant engineering hurdles remaining in the brain-computer interface field, even for companies with substantial funding and high valuations. This setback, focusing on an external component rather than the implant itself, underscores the complexity of reliably translating delicate neural signals into actionable commands for external devices. The company's decision to bring lead design and manufacturing in-house signals a strategic shift towards greater control over critical hardware elements, suggesting that external dependencies may have contributed to previous performance issues.

Synchron's pivot to redesigning the entire Stentrode system, including a new undisclosed device aiming to operate 'beyond the blood vessels,' indicates an ambitious R&D roadmap. This development might signal a broader industry trend towards more sophisticated, multi-modal BCI solutions that integrate various technological approaches. As AI continues to accelerate the interpretation of brain patterns, hardware reliability and iterative design become paramount for translating theoretical potential into practical, patient-ready applications.

AI-written summary. May contain errors.

Synchron